MoneyWorks4Me

Hindustan Bio Sciences informs about outcome of board meeting

31 Oct 2025 Evaluate
Hindustan Bio Sciences has informed that pursuant to Regulation 30 and other applicable Regulations of SEBI (LODR), 2015, the Board of Directors of the Company in its meeting held today i.e., on October 81, 2025 approved the Un-Audited Standalone Financial Results of the company for the 5 Quarter ended on 30th September 2025 along with the Limited Review Report. The meeting commenced at 02:00 PM and concluded at 4.30 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..